BioCentury
ARTICLE | Clinical News

Multikine: CELI began a Canadian Phase I/II trial

July 15, 1996 7:00 AM UTC

Cel-Sci Corp. (CELI), Alexandria, Va. Product: Multikine, a natural source combination of cytokines, including interleukin-2 Indication: Advanced head and neck cancer Status: CELI began a Canadian Ph...